To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Jackson Laboratory Cancer Center Chooses LIMS for Next Generation Sequencing Research
Read time: Less than a minute
Dr Douglas Hinerfeld, senior manager of the Molecular Phenotyping labs at the Laboratory, commented, “The complexity of the sequencing library methodologies, including the use of barcodes for multiplexing, in addition to the sheer data volumes generated by the sequencer, highlights the need for a flexible LIMS. Geneus was the best commercial system for our lab, because it’s flexible, extendible and built specifically for genomics and next-gen sequencing research.”
An NCI-designated Cancer Center, The Jackson Laboratory focuses on mammalian genetics research to advance human health. Its mission is to discover the genetic basis for preventing, treating and curing human disease, and to enable research for the global biomedical community.
The Laboratory’s core next-gen sequencing facility will employ Geneus to enable the technical teams’ sample tracking, automation and pipelining, and to extend project management and operational reporting capabilities to the management team. The Jackson Laboratory chose the Geneus solution because it is designed for life sciences research, supports a variety of genomics applications, and has special features to enable next-generation sequencing research. Geneus will provide the Laboratory with support for multiplexing workflows, high volume sample throughput and data management.
Jackson Laboratory has an aggressive schedule to get Geneus into production. GenoLogics estimates the implementation timeframe from project kick-off to production will be less than four months.
An NCI-designated Cancer Center, The Jackson Laboratory focuses on mammalian genetics research to advance human health. Its mission is to discover the genetic basis for preventing, treating and curing human disease, and to enable research for the global biomedical community.
The Laboratory’s core next-gen sequencing facility will employ Geneus to enable the technical teams’ sample tracking, automation and pipelining, and to extend project management and operational reporting capabilities to the management team. The Jackson Laboratory chose the Geneus solution because it is designed for life sciences research, supports a variety of genomics applications, and has special features to enable next-generation sequencing research. Geneus will provide the Laboratory with support for multiplexing workflows, high volume sample throughput and data management.
Jackson Laboratory has an aggressive schedule to get Geneus into production. GenoLogics estimates the implementation timeframe from project kick-off to production will be less than four months.
